| Author |
Title |
JournalName |
Year D |
| Click on Column Headers to Re-Sort The Current List |
| Isbell H |
A comparison of LSD-25 with (-)-delta9-trans-tetrahydrocannabinol (THC... |
Psychopharmacologia |
1969 |
| Domino EF, Bartolini A |
Effects of various psychotomimetic agents on the EEG and acetylcholine... |
Neuropharmacoloy |
1972 |
| Watanabe S, Nishi H, Ueki... |
Electroencephalographic effects of delta9-tetrahydrocannabinol, LSD-25... |
Jap. J. Pharmacol. |
1972 |
| Drew WG, Miller LL, Baugh... |
Effects of delta9-THC, LSD-25 and scopolamine on continuous, spontaneo... |
Psychopharmacologia |
1973 |
| Henriksson BG, Johansson ... |
Delta 9 Tetrahydrocannabinol Produced Discrimination In Pigeons |
Pharm Biochem Behav |
1975 |
| Munson AE, Harris LS, Fri... |
Antineoplastic activity of cannabinoids |
J Natl Cancer Inst |
1975 |
| Marshman JA, Popham RE, Y... |
A note on the cannabinoid content of Jamaican ganja |
Bull Narc |
1976 |
| West LG, McLaughlin JL |
Triterpenes from the button cactus, Epithelantha micromeris |
Lloydia |
1977 |
| Perez-Reyes M, Wall ME |
Presence of delta9-tetrahydrocannabinol in human milk |
N Engl J Med |
1982 |
| Matthias P, Tashkin DP, M... |
Effects of varying marijuana potency on deposition of tar and delta9-T... |
Pharmacol Biochem Be... |
1997 |
| Smith FL, Cichewicz D, Ma... |
The enhancement of morphine antinociception in mice by delta9-tetrahyd... |
Pharmacol Biochem Be... |
1998 |
| Gessa GL, Casu MA, Carta ... |
Cannabinoids decrease acetylcholine release in the medial-prefrontal c... |
Eur J Pharmacol |
1998 |
| Gessa GL, Casu MA, Carta ... |
Cannabinoids decrease acetylcholine release in the medial-prefrontal c... |
Eur J Pharmacol |
1998 |
| Galve-Roperh I, Saˇnchez ... |
Anti-tumoral action of cannabinoids: involvement of sustained ceramide... |
Nat Med |
2000 |
| van der Stelt M, Veldhuis... |
Neuroprotection by Delta9-tetrahydrocannabinol, the main active compou... |
J Neurosci |
2001 |
| Sidney S |
Cardiovascular consequences of marijuana use |
J Clin Pharmacol |
2002 |
| Justinova Z, Tanda G, Red... |
Self-administration of delta9-tetrahydrocannabinol (THC) by drug naive... |
Psychopharmacology (... |
2003 |
| Morgan CJ, Curran HV |
Effects of cannabidiol on schizophrenia-like symptoms in people who us... |
Br J Psychiatry |
2008 |
| Larson SJ, Holler JM, Mag... |
Papain adulteration in 11-nor-Delta9-tetrahydrocannabinol- 9-carboxyli... |
J Anal Toxicol |
2008 |
| Bossong MG, van Berckel B... |
Delta9-Tetrahydrocannabinol Induces Dopamine Release in the Human Stri... |
Neuropsychopharmacol... |
2008 |
| Fusar-Poli P, Crippa JA, ... |
Distinct effects of {delta}9-tetrahydrocannabinol and cannabidiol on n... |
Arch Gen Psychiatry |
2009 |
| Salazar M, Carracedo A, S... |
Cannabinoid action induces autophagy-mediated cell death through stimu... |
J Clin Invest |
2009 |
| Bossong MG, Niesink RJ |
Adolescent brain maturation, the endogenous cannabinoid system and the... |
Prog Neurobiol |
2010 |
| Fattore L, Fratta W |
Beyond THC: the new generation of cannabinoid designer drugs |
Frontiers in Behavio... |
2011 |
| Hyatt WS, Fantegrossi WE |
Delta9-THC exposure attenuates aversive effects and reveals appetitive... |
Behav Pharmacol |
2014 |
